AlzU Icon
Alzheimer's Universe

Discussion Forum

AlzU Home > Forum > Welcome! > Topic


Posted by john  
January 25, 2016 11:20AM
Can somoene please comment on the effectiveness of IVIG Treatment for patients with early stage. Specifically those who carry ApoE4 allele.

March 09, 2016 10:23PM
Hi John

This is a good question. Currently IVIg is not FDA-approved for the treatment of Alzheimer's disease. There was a study published a few years back that was "negative" but showed a possible signal of having a mild degree of effect in a certain subset of patients, those who were carriers of the APOE4 gene.

Overall, most physicians do not advocate for the use of IVIg due to the limited evidence and high cost, as well as some chance for side effects. Further studies would need to be done to help clarify if IVIg works in specific subgroups and to better answer your question.

For more information, read about the study done at Weill Cornell Medicine / NewYork-Presbyterian a few years ago, [] and be sure to discuss any and all treatment options and seek approval and discussion of risks/benefits for all therapies with a qualified medical professional.

- The AlzU Team
Sorry, only registered users may post in this forum.

Click here to login

Why Join?

Alzheimer's Universe has been created by medical experts to help learn the latest about AD diagnosis, treatment & prevention

Sign Up

Prevention & Treatment

Learn about the latest tips used to help reduce AD risk, delay onset of symptoms, and how to manage AD using a comprehensive approach

Join Now

Learn More

Click on the button below to learn about why Alzheimer's Universe was created, how it works, and what to expect after joining

Learn More

As Seen On:

The Today Show

Share with friends and family: